Works matching IS 02704137 AND DT 2022 AND VI 82 AND IP 15

Results: 9

Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6‐mediated Axl and RON signaling.
Published in:
Prostate, 2022, v. 82, n. 15, p. 1422, doi. 10.1002/pros.24416
By:
- Brown, Nicholas E.;
- Jones, Angelle;
- Hunt, Brian G.;
- Waltz, Susan E.
Publication type:
Article
Issue Information.
Published in:
Prostate, 2022, v. 82, n. 15, p. 1413, doi. 10.1002/pros.24165
Publication type:
Article
Association between duration of gonadotrophin‐releasing hormone agonist use and cardiovascular risks: A population‐based competing‐risk analysis.
Published in:
Prostate, 2022, v. 82, n. 15, p. 1477, doi. 10.1002/pros.24423
By:
- Chan, Jeffrey S. K.;
- Tang, Pias;
- Hui, Jeremy M. Ho;
- Lee, Yan H. A.;
- Dee, Edward C.;
- Ng, Kenrick;
- Liu, Kang;
- Tse, Gary;
- Ng, Chi Fai
Publication type:
Article
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index.
Published in:
Prostate, 2022, v. 82, n. 15, p. 1469, doi. 10.1002/pros.24422
By:
- Terracciano, Daniela;
- La Civita, Evelina;
- Athanasiou, Alcibiade;
- Liotti, Antonietta;
- Fiorenza, Mariano;
- Cennamo, Michele;
- Crocetto, Felice;
- Tennstedt, Pierre;
- Schiess, Ralph;
- Haese, Alexander;
- Ferro, Matteo;
- Steuber, Thomas
Publication type:
Article
Comparison of 68Ga‐PSMA PET/CT and mp‐MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study.
Published in:
Prostate, 2022, v. 82, n. 15, p. 1462, doi. 10.1002/pros.24420
By:
- Ucar, Taha;
- Gunduz, Nesrin;
- Demirci, Emre;
- Culpan, Meftun;
- Gunel, Humeyra;
- Kir, Gozde;
- Atis, Ramazan Gokhan;
- Yildirim, Asif
Publication type:
Article
Prognostic role of pan‐immune‐inflammation value in patients with metastatic castration‐resistant prostate cancer treated with androgen receptor‐signaling inhibitors.
Published in:
Prostate, 2022, v. 82, n. 15, p. 1456, doi. 10.1002/pros.24419
By:
- Yazgan, Satı Coşkun;
- Yekedüz, Emre;
- Utkan, Güngör;
- Ürün, Yüksel
Publication type:
Article
Using health insurance claims data to assess long‐term disease progression in a prostate cancer cohort.
Published in:
Prostate, 2022, v. 82, n. 15, p. 1447, doi. 10.1002/pros.24418
By:
- Khan, Saira;
- Vohra, Sanah;
- Farnan, Laura;
- Elmore, Shekinah N. C.;
- Toumbou, Khadijah;
- K. C., Madhav;
- Fontham, Elizabeth T. H.;
- Peters, Edward S.;
- Mohler, James L.;
- Bensen, Jeannette T.
Publication type:
Article
Better preservation of erectile function in localized prostate cancer patients with modern proton therapy: Is it cost‐effective?
Published in:
Prostate, 2022, v. 82, n. 15, p. 1438, doi. 10.1002/pros.24417
By:
- Li, Guo;
- Xia, Yun‐Fei;
- Huang, Yi‐Xiang;
- Okat, Deniz;
- Qiu, Bo;
- Doyen, Jerome;
- Bondiau, Pierre‐Yves;
- Benezery, Karen;
- Gao, Jin;
- Qian, Chao‐Nan
Publication type:
Article
Optimization of prostate cancer patient lymph node staging via the integration of neutrophil–lymphocyte ratios, platelet–lymphocyte ratios, and <sup>68</sup>Ga‐PSMA‐PET‐derived SUVmax values.
Published in:
Prostate, 2022, v. 82, n. 15, p. 1415, doi. 10.1002/pros.24415
By:
- Wang, Yinzhao;
- Tang, Yongxiang;
- Gao, Xiaomei;
- Gan, Yu;
- Hu, Shuo;
- Chen, Min‐Feng;
- Cai, Yi
Publication type:
Article